| dc.contributor.author | Mondal, Shamim S. | |
| dc.contributor.author | Pingali, Viswanath | |
| dc.date.accessioned | 2015-12-18T07:13:26Z | |
| dc.date.available | 2015-12-18T07:13:26Z | |
| dc.date.copyright | 2015 | |
| dc.date.issued | 2015 | |
| dc.identifier.uri | http://hdl.handle.net/11718/17052 | |
| dc.description.abstract | The Indian pharmaceutical industry is one of the largest in the world both in terms of volume and value. Given its critical importance, the sector has been subject to a series of regulatory interventions, which have altered the nature of the industry quite significantly. With enacting the Indian competition Act (2002), India has joined the list of countries that has a robust competition regime. The purpose of this chapter is to understand the pharmaceutical sector through the prism of competition law. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Indian Institute of Management Ahmedabad | en_US |
| dc.relation.ispartofseries | WP;20151102 | |
| dc.subject | Competition Law | en_US |
| dc.subject | Pharmaceutical Sector | en_US |
| dc.title | Competition Law and the Pharmaceutical Sector in India | en_US |
| dc.type | Working Paper | en_US |
